跳至主要内容
临床试验/NCT05255978
NCT05255978招募中不适用

A Prospective/Retrospective, Observational Follow-up Study of Chronic Hepatitis B With Non-alcoholic Fatty Liver Disease.

Qin Ning1 个研究点 分布在 1 个国家目标入组 10,000 人开始时间: 2022年2月24日最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
发起方
入组人数
10,000
试验地点
1
主要终点
disease progression

研究概览

简要总结

This is a prospective/retrospective, observational follow-up study of effects of fatty liver on chronic hepatitis B. Patients will join this study who undergo transient elastography with liver stiffness (LS) and CAP measurements or Ultrasonic examination. All recruited subjects will undergo comprehensive clinical, anthropometric and laboratory assessments at the time when transient elastography or Ultrasonic examination is performed. We plan to compare the relationship between chronic hepatitis B and non-alcoholic fatty liver disease. Patients will be divided into several groups based on the demand.

研究设计

研究类型
Observational
观察模型
Case Control
时间视角
Prospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • age > 18 years, chronic hepatitis B patients -

排除标准

  • patients with chronic hepatitis C or D and human immunodeficiency virus co-infection, excessive alcohol intake (≥30 g/d for men, ≥20 g/d for women), other chronic liver diseases (e.g. primary biliary cholangitis, primary sclerosing cholangitis, autoimmune hepatitis, Wilson's disease), or on medications known to induce hepatic steatosis (including corticosteroids, methotrexate, and tamoxifen), and pregnancy.

结局指标

主要结局

disease progression

时间窗: 3 years to 10 years

the effect of NAFLD on CHB

次要结局

未报告次要终点

研究者

发起方
Qin Ning
申办方类型
Other
责任方
Sponsor Investigator
主要研究者

Qin Ning

Director and Chair of Department of Infectious Diseases

Tongji Hospital

研究点 (1)

Loading locations...

相似试验